Alkem Laboratories Q1 Results FY26: Q1 PAT Rises 21.85% to ₹664.26 Crore; Revenue Up 11.19% YoY

Alkem Laboratories Q1 Results FY26: Alkem Laboratories posted its Q1 results on 12th August 2025. The company posted robust numbers, with Q1 PAT standing at ₹664.26 crores against revenue of ₹3,371.14 crores. During Q1 FY26, the profit increase of the company was recorded at 21.85% YoY, and the revenue increase for the same period was 11.19%. 

Alkem Laboratories Q1 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)

(Figures in crores)

Alkem Laboratories Q1 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)

(Figures in crores)

Alkem Laboratories Q1 Results FY26 Highlights (Q1 FY26 vs FY25)

• Alkem Laboratories clocked Q1 FY26 consolidated revenue of ₹3,371.14 crores vs ₹3,3031.82 crores. 
• On the profit front, Alkem Laboratories earned a consolidated PAT of ₹664.26 crore in Q1 FY26. During FY25, the company’s PAT stood at ₹545.16 crore. 
• Consolidated PAT rose for the first quarter of FY26, was 21.85% YoY, and revenue increased by 11.19% YoY. 
• As per the standalone figures, the quarterly PAT of Alkem Laboratories has increased by 14.02%, and revenue has increased by 11.53% YoY.

Alkem Laboratories Share Price Performance

On the opening bell of 12th August 2025, the shares of Alkem Laboratories opened at ₹4,865.00 per share. However, the initial gains are sustained as of now, and Alkem Laboratories shares are trading at ₹5,165.00 per share, higher than their opening price. 

Considering the long-term performance, Alkem Laboratories shares have yielded close to -9.62% returns in the past 1 year, and 5-year returns stand at 76.57%. Over the maximum timeframe, the Alkem Laboratories share provided 238.97% returns to investors. However, one must ignore the risk of volatility in the stock market and invest in Alkem Laboratories shares after thorough research. 

For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your research before investing in shares and other securities.

Also Read : Bajaj Holdings & Investment Q1 Results FY26: Q1 PAT Soars 116.49% to ₹3,486.51 Crore; Revenue Jumps 142.72% YoY

Recent Articles

HBL Engineering Q1 Results FY26: Q1 PAT Rises 78.87% to ₹143.27 Crore; Revenue Up 15.70% YoY

Fine Organic Q1 Results FY26: Q1 PAT Rose 7.04% to ₹117.10 Crore; Revenue Up 7.04% YoY

Eureka Forbes Q1 Results FY26: Q1 PAT Rises 20.32% to ₹38.68 Crore; Revenue Up 9.85% YoY

JM Financial Q1 Results FY26: Q1 PAT Rose 165.85% to ₹453.81 Crore; Revenue Up 3.18% YoY

IPCA Laboratories Q1 Results FY26: Q1 PAT Rises 21.31% to ₹233.21 Crore; Revenue Up 10.33% YoY